Cigarette smoke doesn’t just harm the lungs; it accelerates the aging process in the eyes, increasing the risk of vision loss from age-related macular degeneration (AMD). A new study from Johns Hopkins University sheds light on the mechanisms behind this connection, revealing that smoking triggers epigenetic changes in critical eye cells, hindering their ability to function and respond to stress. Understanding how cigarette smoke impacts the eye at a molecular level could pave the way for new preventative strategies and treatments for AMD, a leading cause of blindness worldwide.
AMD affects the macula, the central part of the retina responsible for sharp, central vision. According to the National Eye Institute, over 11 million Americans have AMD, and that number is projected to rise as the population ages. Even as age is the primary risk factor, lifestyle choices, particularly smoking, significantly influence its development and progression. Smokers are four times more likely to develop AMD than non-smokers, a link long recognized by researchers, but the underlying biological processes have remained elusive.
How Smoking Alters Eye Cells
The recent research, published in the Proceedings of the National Academy of Sciences, focused on retinal pigmented epithelial (RPE) cells. These cells are essential for maintaining the health of photoreceptors – the light-sensing cells that allow us to witness. RPE cells provide nutrients to photoreceptors and remove waste products, acting as a crucial support system. Researchers, led by James T. Handa, chief of the retina division at the Wilmer Eye Institute at Johns Hopkins University, investigated how exposure to cigarette smoke affects these vital cells.
The team compared RPE cells from mice of different ages – 3 months (young adulthood) and 12 months (late middle age in human terms) – after both acute (single exposure) and chronic (four months of daily exposure) to cigarette smoke. Using genetic sequencing, they discovered that smoke exposure caused epigenetic changes in the RPE cells. Epigenetics refers to modifications in gene expression that don’t involve alterations to the underlying DNA sequence. These changes can effectively switch genes “on” or “off,” influencing cell function.
“Smoking is often assumed to accelerate aging by releasing tissue-damaging molecules called free radicals,” explained Handa. However, the study demonstrates that the epigenetic impact of smoke is a significant contributor to eye aging. The researchers found that smoke exposure led to decreased expression of genes crucial for RPE cell function and a reduction in “chromatin accessibility” – the ability of cellular machinery to access and regulate genes. This limited the cells’ ability to adapt and survive.
Hallmarks of Aging in the Retina
The study identified specific “hallmarks of aging” genes that were affected by cigarette smoke. These genes are involved in processes like genomic instability (damage to DNA), telomere shortening (shrinkage of protective caps on the ends of chromosomes), and mitochondrial dysfunction (impaired energy production within cells). The presence of these hallmarks in RPE cells exposed to smoke mirrored the characteristics observed in human eyes with AMD.
Interestingly, the researchers observed differences in the gene expression patterns between young and aged mice. Young mice exposed to smoke showed a distinct set of aging-related gene changes compared to older mice. This suggests that the impact of smoking on the eye may be particularly damaging during early adulthood, potentially setting the stage for future vision problems.
Bridging the Gap to Human Disease
To further validate their findings, the team analyzed RPE cells donated by humans – two individuals without AMD who had never smoked, one non-AMD individual who smoked, and one person with early AMD. They identified 1,698 genes that showed altered expression in both the dysfunctional mouse RPE cells and the human cells affected by smoking or AMD. This overlap suggests that the molecular mechanisms identified in the mouse model are relevant to the development and progression of AMD in humans.
The researchers emphasize that this is just the beginning. “Knowing environmental stress can interfere with the eye’s ability to produce the genes needed to stay healthy, we now desire to narrow down which changes are temporary and which are permanent,” Handa stated. His team is now focused on understanding how prolonged smoke exposure and age interact to cause eye damage and contribute to the development of late-stage AMD.
This research was supported by grants from the National Institutes of Health, the Research to Prevent Blindness Stein Innovation Award, and the BrightFocus Foundation. Handa also disclosed financial ties to Character Biosciences, Cirrus Pharmaceuticals, and Seeing Medicines.
Disclaimer: This article provides information for general knowledge and informational purposes only, and does not constitute medical advice. It is essential to consult with a qualified healthcare professional for any health concerns or before making any decisions related to your health or treatment.
The findings underscore the importance of avoiding smoking to protect vision health. As researchers continue to unravel the complex interplay between environmental factors, genetics, and aging in AMD, the hope is to develop targeted interventions that can prevent or slow the progression of this debilitating disease. The Johns Hopkins team plans to continue characterizing the long-term effects of smoking on the eye, with ongoing studies expected to provide further insights in the coming years.
Have thoughts on this research? Share your comments below, and please consider sharing this article with anyone concerned about protecting their vision.
